Content Type: Research Publications

Internet Searches for Unproven COVID-19 Therapies in the United States

March 15, 2026

Lung Cancer Survival Gains: Contributions of Academia and Industry

March 15, 2026

False Negative Tests for SARS-CoV-2 Infection—Challenges and Implications

March 15, 2026

Surrogate Endpoints and Drug Regulation: What Is Needed to Clarify the Evidence

March 15, 2026

Characteristics of Recent Generic Drug Approvals By the US Food and Drug Administration

March 15, 2026

Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions

March 15, 2026

Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers

March 15, 2026

Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States

March 15, 2026

Potential Medicare Savings on Inhaler Prescriptions Through the Use of Negotiated Prices and a Defined Formulary

March 15, 2026

Sponsorship and Funding for Gene Therapy Trials in the United States

March 15, 2026

Estimation of Medicare Part D Spending on Insulin for Patients with Diabetes Using Negotiated Prices and a Defined Formulary

March 15, 2026

Evaluating the Evidence Behind the Surrogate Measures Included in the FDA’s Table of Surrogate Endpoints as Supporting Approval of Cancer Drugs

March 15, 2026